Acute intracerebral hemorrhage may occur in patients on factor Xa inhibitors. The efficacy and safety of the FXa inhibitor reversal agent andexanet for limiting ICH volume expansion are unknown.
Research findings are summarized in a new Quick Take video.
To see the full article, follow this link: nej.md/3wAoERb
#neurology #hematology #emergencymedicine #clinicaltrials #nejm
Негізгі бет Ғылым және технология Andexanet for FXa Inhibitor-Associated Acute ICH | NEJM
Пікірлер: 2